What is Mounjaro?

Mounjaro (tirzepatide) is a breakthrough medication originally approved for type 2 diabetes that has shown significant effectiveness for weight management. It represents a new class of dual-action agonists.

How Mounjaro Works

Unlike other weight loss injections that target a single hormone, Mounjaro mimics two natural hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual mechanism helps to:

• Regulate blood sugar levels more effectively
• Slow down gastric emptying, keeping you fuller for longer
• Signal the brain to reduce appetite and food cravings

Clinical Effectiveness

Clinical trials have demonstrated impressive results. In studies, participants taking the highest dose of Mounjaro lost an average of up to 20% of their body weight over 72 weeks, when combined with diet and exercise.

Dosage Schedule

Mounjaro is administered as a once-weekly injection. The typical dosing schedule involves starting at a low dose and gradually increasing it to minimize side effects:

• Weeks 1-4: 2.5 mg (Starting dose)
• Weeks 5-8: 5 mg
• Weeks 9-12: 7.5 mg
• Maintenance: Doses can go up to 15 mg depending on tolerance and goals.